Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.43 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | AHR | P35869 | 2/20 | 0.42 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30960269 | 1.00 | MAPT (0.46) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL22377057 | 0.98 | PLA2G2A (0.46) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL30973822 | 0.95 | PLA2G2A (0.48) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL16441416 | 0.95 | MAPT (0.50) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL15835959 | 0.93 | MAPT (0.49) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL22376020 | 0.92 | PLA2G2A (0.43) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL29761259 | 0.92 | AHR (0.45) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL18215027 | 0.92 | AHR (0.45) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL23268362 | 0.92 | HPGD (0.50) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 | |
| SCHEMBL17214814 | 0.92 | HPGD (0.50) | MAPTHPGDNPC1SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4282863-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Universal Display Corporation (US) | 2023-11-29 | — | — | EP | disclosed |
| US-20230286989-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-14 | — | — | US | disclosed |
| US-11744151-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-20230225203-A1 | ORGANIC LUMINESCENT ELEMENT | KYULUX, INC. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-11569455-B2 | Compound for organic optoelectronic device, organic optoelectronic device, and display device | SAMSUNG SDI CO., LTD. (KR) | 2023-01-31 | — | — | US | disclosed |
| US-20200395551-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2020-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744151-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | MAPT 567/4885HPGD 832/4885NPC1 2142/4885 |
| US-20230286989-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ODC1 | MAPT 966/4885HPGD 474/4885NPC1 1673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.